Abstract:AIM: To observe the effect of transplanted olfactory ensheathing cells on the somatosensory and motor evoked potentials in spinal cord injured rats, and try to make use of transplanted olfactory ensheathing cells transduction pathway to repair the spinal cord injury. METHODS: The experiment was accomplished in the oral medicine experiment center of Xi'an Jiaotong University from September 2004 to July 2006. ①Forty healthy adult SD rats were selected, of which 16 ones were selected for the culture and purification of olfactory ensheathing cells; the left rats were randomly divided into 4 groups: sham operated group, model group, olfactory ensheathing cells transplantation (OECs) group, and DF12 culture solution group with 6 rats in each group. ②The models of spinal cord injury were made in the latter three groups by spinal cord transection. From the post median incision with T10 as the center, the whole vertebral plate of T10 and part plate of T9 and T11 were removed to expose the spinal cord; 3-0 suture silk was located at the ventral extradural space before injured with a specially made explorer, and the spinal cord was completely transected with a shaving knife at 0.5 mm (parallel to T10) away from the preset thread. The sham operated group was simply given laminectomy. ③After modeling, 0.5 μL OECs culture fluid was injected in the OECs group from 1 mm cranial and caudal to the lesion epicenter with 4 depths of 1.75, 1.25, 1.00 and 0.50 mm; the injection speed was 0.1 μL per minute and the needle of each level one injection remained in 5 minutes. DF12 group was injected with 0.5 μL DF12 culture fluid with the previous method. The sham operated and model groups were not given any treatment. ④Amplitude and latency changes of somatosensory and motor evoked potential of rats were assessed postoperative 8 week under anesthesia with Dantec Keypoint four conduct type evoked potentials.RESULTS: Twenty-four SD rats were all involved in the result analysis. ①General view after OECs transplantation: Six weeks after operation, hind limb creeper and ulcer, sore and other denervated signs of bilateral knee and ankle joint were improved; the quadriceps femoris muscle force was recovered significantly, while the denervated signs of the model group and DF12 group were not improved, and no abnormality was found in the sham operated group. ②Somatosensory evoked potentials examination postopertative 8 week: The waveform of somatosensory evoked potentials was not elicited in the model group and DF12 group. Compared with the sham operated group, the latency of somatosensory evoked potentials of the OECs group were significantly extended [(2.640±0.294), (14.575±2.117) ms, P < 0.01], and the amplitude was decreased [(3.797±0.140), (0.403±0.078) μV, P < 0.01]. ③ Waveform of motor evoked potentials was not elicited in the model group and DF12 group. Compared with the sham operated group, the latency of motor evoked potentials of OECs group were significantly extended [(5.825±0.350), (10.750±1.184) ms, P < 0.01], and the amplitude was decreased [(5.200±0.432), (0.10±0.001) μV, P < 0.01]. CONCLUSION: Olfactory ensheathing cells transplantation could adjust the internal microenvironment of injured spinal cord, enhance the recovery of somatosensory and motor evoked potentials and improve the neural function.

Microencapsulation Improves Inhibitory Effects of Transplanted Olfactory Ensheathing Cells on Pain after Sciatic Nerve Injury

Microencapsulated olfactory ensheathing cells transplantation alleviates peripheral nerve injury pain and down-regulates P2X3 purine receptor expression in dorsal root ganglion

Transplantation of Microencapsulated Olfactory Ensheathing Cells Inhibits the P2X2 Receptor Over-Expressionmediated Neuropathic Pain in the L4-5 Spinal Cord Segment

Microencapsulated Olfactory Ensheathing Cell Transplantation Reduces P2X4 Receptor Overexpression and Inhibits Neuropathic Pain in Rats

Microencapsulated Olfactory Ensheathing-Cell Transplantation Reduces Pain in Rats by Inhibiting P2X4 Receptor Overexpression in the Dorsal Root Ganglion

The Effect of Microencapsulated Olfactory Ensheathing Cell Transplantation on P2X2 and P2X3 ;Receptor-Mediated Neuropathic Pain

Effects of Microencapsulated Olfactory Ensheathing Cell Transplantation on Neuropathic Pain and P2X7 Receptor Expression in the L4-5 Spinal Cord Segment.

Microencapsulated Schwann Cell Transplantation Inhibits P2X2/3 Receptors Overexpression in a Sciatic Nerve Injury Rat Model with Neuropathic Pain

Microencapsulated Schwann Cell Transplantation Inhibits P2X3 Receptor Expression in Dorsal Root Ganglia and Neuropathic Pain.

Chitosan biomaterial enhances the effect of OECs on the inhibition of sciatic nerve injury-induced neuropathic pain

OECs Transplantation Results in Neuropathic Pain Associated with BDNF Regulating ERK Activity in Rats Following Cord Hemisection.

The anti-inflammatory and immunomodulatory effects of olfactory ensheathing cells transplantation in spinal cord injury and concomitant pathological pain

Transplantation of NSCs with OECs Alleviates Neuropathic Pain Associated with NGF Downregulation in Rats Following Spinal Cord Injury

Intrathecal Implantation of Microencapsulated PC12 Cells Reduces Cold Allodynia in a Rat Model of Neuropathic Pain.

Olfactory ensheathing cells and neuropathic pain

Improved Neural Regeneration with Olfactory Ensheathing Cell Inoculated PLGA Scaffolds in Spinal Cord Injury Adult Rats.

Subarachnoid implantation of microencapsulated PC12 cells reduces cold allodynia in a rat model of neuropathic pain

Transplantation of olfactory ensheathing cells can alleviate neuroinflammatory responses in rats with trigeminal neuralgia

Effect of olfactory ensheathing cell transplantation on the evoked potentials of rats with spinal cord injury

Effect of olfactory ensheathing cell transplantation on NogoA protein levels in the injured spinal cord region

[Effect of Olfactory Ensheathing Cells Transplantation on Protecting Spinal Cord and Neurons after Peripheral Nerve Injury].